Abstract
While the effects of interleukin-3 (IL-3) and granulocyte macrophage-colony stimulating factor (GM-CSF) on microglia are well documented, very little is known about the effects of a related cytokine, interleukin-5 (IL-5). We therefore undertook studies to determine how IL-5 alters various aspects of microglial functioning. Treatment of microglia with IL-5 resulted in the induction of proliferation at levels similar to those induced by GM-CSF. IL-5 also increased cellular metabolism of microglial cells. To determine whether increased metabolism correlated with activation of microglia, we measured levels of nitrite, a breakdown product of nitric oxide. Treatment of microglial cultures with IL-5 increased nitrite levels, while GM-CSF treatment had no effect. Treatment of microglia with IL-5 did not cause activation of the signal transduction pathways linked to the classical IL-5 receptor, STAT5A/5B and ERK1 and ERK2. It is therefore likely that the effects of IL-5 on microglia are not mediated via the classical IL-5 receptor, but rather via a novel receptor.
Similar content being viewed by others
REFERENCES
Ling, E. A. and Wong, W. C. 1993. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7:9–18.
Gehrmann, J., Matsumoto, Y., and Kreutzberg, G. W. 1995. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 20:269–287.
Frei, K., Bodmer, S., Schwerdel, C., and Fontana, A. 1986. Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. J. Immunol. 137:3521–3527.
Ganter, S., Northoff, H., Männel, D., and Gebicke-Härter, P. J. 1992. Growth control of cultured microglia. J. Neurosci. Res. 33:218–230.
Giulian, D. and Ingeman, J. E. 1988. Colony-stimulating factors as promoters of ameboid microglia. J. Neurosci. 8:4707–4717.
Kloss, C. U., Kreutzberg, G. W., and Raivich, G. 1997. Proliferation of ramified microglia on an astrocyte monolayer: characterization of stimulatory and inhibitory cytokines. J. Neurosci. Res. 49:248–254.
Lee, S. C., Liu, W., Brosnan, C. F., and Dickson, D. W. 1994. GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12:309–318.
Suzumura, A., Sawada, M., Yamamoto, H., and Marunouchi, T. 1990. Effects of colony stimulating factors on isolated microglia in vitro. J. Neuroimmunol. 30:111–120.
Hayashi, M., Dorf, M. E., and Abromson-Leeman, S. 1993. Granulocyte-macrophage colony stimulating factor inhibits class II major histocompatibility complex expression and antigen presentation by microglia. J. Neuroimmunol. 48:23–32.
Fischer, H. G., Bielinsky, A. K., Nitzgen, B., Däubener, W., and Hadding, U. 1993. Functional dichotomy of mouse microglia developed in vitro: differential effects of macrophage and granulocyte/macrophage colony-stimulating factor on cytokine secretion and antitoxoplasmic activity. J. Neuroimmunol. 45:193–201.
Imamura, K., Suzumura, A., Sawada, M., Mabuchi, C., and Marunouchi, T. 1994. Induction of MHC class II antigen expression on murine microglia by interleukin-3. J. Neuroimmunol. 55:119–125.
Fujita, H., Tanaka, J., Toku, K., Tateishi, N., Suzuki, Y., Matsuda, S., Sakanaka, M., and Maeda, N. 1996. Effects of GMCSF and ordinary supplements on the ramification of microglia in culture: a morphometrical study. Glia 18:269–281.
Suzumura, A., Sawada, M., and Marunouchi, T. 1996. Selective induction of interleukin-6 in mouse microglia by granulocytemacrophage colony-stimulating factor. Brain Res. 713:192–198.
Matyszak, M. K., Denis-Donini, S., Citterio, S., Longhi, R., Granucci, F., and Ricciardi-Castagnoli, P. 1999. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation. Eur. J. Immunol. 29:3063–3076.
Jander, S., Schroeter, M., Fischer, J., and Stoll, G. 2000. Differential regulation of microglial keratan sulfate immunoreactivity by proinflammatory cytokines and colony-stimulating factors. Glia 30:401–410.
Sawada, M., Itoh, Y., Suzumura, A., and Marunouchi, T. 1993. Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci. Lett. 160:131–134.
Kitamura, T., Sato, N., Arai, K., and Miyajima, A. 1991. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 66:1165–1174.
Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Cleveland, J. L., Yi, T., and Ihle, J. N. 1993. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc. Natl. Acad. Sci. USA 90:8429–8433.
Quelle, F. W., Sato, N., Witthuhn, B. A., Inhorn, R. C., Eder, M., Miyajima, A., Griffin, J. D., and Ihle, J. N. 1994. JAK2 associates with the beta c chain of the receptor for granulocytemacrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14:4335–4341.
Brizzi, M. F., Zini, M. G., Aronica, M. G., Blechman, J. M., Yarden, Y., and Pegoraro, L. 1994. Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase. J. Biol. Chem. 269:31680–31684.
Mui, A. L., Wakao, H., O'Farrell, A. M., Harada, N., and Miyajima, A. 1995. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. Embo J. 14:1166–1175.
Okuda, K., Sanghera, J. S., Pelech, S. L., Kanakura, Y., Hallek, M., Griffin, J. D., and Druker, B. J. 1992. Granulocytemacrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood 79:2880–2887.
Tavernier, J., Devos, R., Cornelis, S., Tuypens, T., Van der Heyden, J., Fiers, W., and Plaetinck, G. 1991. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66:1175–1184.
Pazdrak, K., Stafford, S., and Alam, R. 1995. The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. J. Immunol. 155:397–402.
Alam, R., Pazdrak, K., Stafford, S., and Forsythe, P. 1995. The interleukin-5/receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras-Raf-1-MAP kinase and the Jak-STAT pathways in eosinophils. Int. Arch. Allergy Immunol. 107:226–227.
Pazdrak, K., Schreiber, D., Forsythe, P., Justement, L., and Alam, R. 1995. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J. Exp. Med. 181:1827–1834.
Takatsu, K., Tominaga, A., Harada, N., Mita, S., Matsumoto, M., Takahashi, T., Kikuchi, Y., and Yamaguchi, N. 1988. T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol. Rev. 102:107–135.
Sanderson, C. J., Campbell, H. D., and Young, I. G. 1988. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol. Rev. 102:29–50.
Sawada, M., Suzumura, A., Itoh, Y., and Marunouchi, T. 1993. Production of interleukin-5 by mouse astrocytes and microglia in culture. Neurosci. Lett. 155:175–178.
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348–2357.
Ando, D. G., Clayton, J., Kono, D., Urban, J. L., and Sercarz, E. E. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:132–143.
Olsson, T. 1995. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 45:S11–15.
Conboy, I. M., DeKruyff, R. H., Tate, K. M., Cao, Z. A., Moore, T. A., Umetsu, D. T., and Jones, P. P. 1997. Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains. J. Exp. Med. 185:439–451.
Crisi, G. M., Santambrogio, L., Hochwald, G. M., Smith, S. R., Carlino, J. A., and Thorbecke, G. J. 1995. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10. Eur. J. Immunol. 25:3035–3040.
Rott, O., Fleischer, B., and Cash, E. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434–1440.
Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M., and Röcken, M. 1994. Cytokineinduced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961–1966.
Cannella, B., Gao, Y. L., Brosnan, C., and Raine, C. S. 1996. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:735–746.
Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R., and Hofman, F. M. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89:574–578.
Ringheim, G. E. 1995. Mitogenic effects of interleukin-5 on microglia. Neurosci. Lett. 201:131–134.
McCarthy, K. D. and de Vellis, J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:890–902.
Cole, R. and de Vellis, J. 1990. Preparation of astrocyte and oligodendrocyte cultures from primary rat glial cultures., Alan R. Liss, New York.
Ignarro, L. J. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:535–560.
Ding, M., Wong, J. L., Rogers, N. E., Ignarro, L. J., and Voskuhl, R. R. 1997. Gender differences of inducible nitric oxide production in SJL/J mice with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 77:99–106.
Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55–63.
Berridge, M. V. and Tan, A. S. 1993. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303:474–482.
Liva, S. M., Kahn, M. A., Dopp, J. M., and de Vellis, J. 1999. Signal transduction pathways induced by GM-CSF in microglia: significance in the control of proliferation. Glia. 26:344–352.
Baumann, M. A. and Paul, C. C. 1997. Interleukin-5 and human B lymphocytes. Methods 11:88–97.
De Simone, R., Giampaolo, A., Giometto, B., Gallo, P., Levi, G., Peschle, C., and Aloisi, F. 1995. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54:175–187.
Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Ledbetter, J. A., Boersma, W. J., and Claassen, E. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93:2499–1504.
Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M., and Khoury, S. 1998. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161:1104–1112.
Aloisi, F., Ria, F., Penna, G., and Adorini, L. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160:4671–4680.
Aloisi, F., Ria, F., Columba-Cabezas, S., Hess, H., Penna, G., and Adorini, L. 1999. Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation. Eur. J. Immunol. 29:2705–2714.
Betz, M. and Fox, B. S. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108–113.
Aloisi, F., Penna, G., Cerase, J., Menéndez Iglesias, B., and Adorini, L. 1997. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159:1604–1612.
Wu, C. Y., Wang, K., McDyer, J. F., and Seder, R. A. 1998. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161:2723–2730.
Stuehr, D. J., Gross, S. S., Sakuma, I., Levi, R., and Nathan, C. F. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011–1020.
Liew, F. Y., Li, Y., and Millott, S. 1990. Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 71:556–559.
Green, S. J., Mellouk, S., Hoffman, S. L., Meltzer, M. S., and Nacy, C. A. 1990. Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes. Immunol. Lett. 25:15–19.
Zielasek, J., Tausch, M., Toyka, K. V., and Hartung, H. P. 1992. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell. Immunol. 141:111–120.
Chao, C. C., Molitor, T. W., and Hu, S. 1993. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151:1473–1481.
Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., Tawadros, R., and Koprowski, H. 1995. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92:12041–12045.
Bö, L., Dawson, T. M., Wesselingh, S., Mörk, S., Choi, S., Kong, P. A., Hanley, D., and Trapp, B. D. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:778–786.
Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., and Tilton, R. G. 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:2684–2690.
Zhao, W., Tilton, R. G., Corbett, J. A., McDaniel, M. L., Misko, T. P., Williamson, J. R., Cross, A. H., and Hickey, W. F. 1996. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:123–133.
Ding, M., Zhang, M., Wong, J. L., Rogers, N. E., Ignarro, L. J., and Voskuhl, R. R. 1998. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160:2560–2564.
Mitrovic, B., Ignarro, L. J., Montestruque, S., Smoll, A., and Merrill, J. E. 1994. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61:575–585.
Zielasek, J., Jung, S., Gold, R., Liew, F. Y., Toyka, K. V., and Hartung, H. P. 1995. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:81–88.
Ruuls, S. R., Van Der Linden, S., Sontrop, K., Huitinga, I., and Dijkstra, C. D. 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:467–474.
Gold, D. P., Schroder, K., Powell, H. C., and Kelly, C. J. 1997. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:2863–2869.
Fenyk-Melody, J. E., Garrison, A. E., Brunnert, S. R., Weidner, J. R., Shen, F., Shelton, B. A., and Mudgett, J. S. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:2940–2946.
Young, M. R., Wright, M. A., Matthews, J. P., Malik, I., and Prechel, M. 1996. Suppression of T cell proliferation by tumorinduced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. J. Immunol. 156:1916–1922.
Bingisser, R. M., Tilbrook, P. A., Holt, P. G., and Kees, U. R. 1998. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J. Immunol. 160:5729–5734.
van der Veen, R. C., Dietlin, T. A., Dixon Gray, J., and Gilmore, W. 2000. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell. Immunol. 199:43–49.
al-Ramadi, B. K., Meissler, J. J., Jr., Huang, D., and Eisenstein, T. K. 1992. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22:2249–2254.
Takagi, K., Nukaya, I., Yasukawa, K., and Suketa, Y. 1994. Inhibitory mechanisms of antibody production by nitrogen oxides released from activated macrophages during the immune response: relationship to energy consumption. Immunol. Cell Biol. 72:241–248.
Lisak, R. P., Zwiman, B., and Norman, M. 1975. Antimyelin antibodies in neurologic diseases. Immunofluorescent demonstration. Arch. Neurol. 32:163–167.
Mathiesen, T., von Holst, H., Fredrikson, S., Wirsén, G., Hederstedt, B., Norrby, E., Sundqvist, V. A., and Wahren, B. 1989. Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system. J. Neurol. 236:238–242.
Zhang, J. W., Lambrechts, J., Heyligen, H., Vandenbark, A. A., and Raus, J. 1989. Human B cell lines secreting IgM antibody specific for myelin basic protein. J. Neuroimmunol. 23:249–256.
Link, H., Baig, S., Jiang, Y. P., Olsson, O., Höjeberg, B., Kostulas, V., and Olsson, T. 1989. B cells and antibodies in MS. Res. Immunol. 140:219–226; discussion 245–248.
Wei, X. Q., Charles, I. G., Smith, A., Ure, J., Feng, G. J., Huang, F. P., Xu, D., Muller, W., Moncada, S., and Liew, F. Y. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408–411.
McInnes, I. B., Leung, B., Wei, X. Q., Gemmell, C. C., and Liew, F. Y. 1998. Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase. J. Immunol. 160:308–315.
Huang, F. P., Niedbala, W., Wei, X. Q., Xu, D., Feng, G. J., Robinson, J. H., Lam, C., and Liew, F. Y. 1998. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur. J. Immunol. 28:4062–4070.
Meldrum, D. R., Shames, B. D., Meng, X., Fullerton, D. A., McIntyre, R. C., Jr., Grover, F. L., and Harken, A. H. 1998. Nitric oxide downregulates lung macrophage inflammatory cytokine production. Ann. Thorac. Surg. 66:313–317.
Magazine, H. I., Chang, J., Goumon, Y., and Stefano, G. B. 2000. Rebound from nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis. J. Immunol. 165:102–107.